Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Documenti analoghi

• Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
  di: Spilman, Patricia, et al.
  Pubblicazione: (2010)
• Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
  di: Patricia Spilman, et al.
  Pubblicazione: (2010-04-01)
• Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
  di: Spilman, Patricia, et al.
  Pubblicazione: (2011)
• Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau: EFFECTS ON COGNITIVE IMPAIRMENTS
  di: Caccamo, Antonella, et al.
  Pubblicazione: (2010)
• Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
  di: Halloran, Jonathan, et al.
  Pubblicazione: (2012)